ES2038687T3 - Procedimiento para la preparacion de nuevos derivados del pirrol. - Google Patents

Procedimiento para la preparacion de nuevos derivados del pirrol.

Info

Publication number
ES2038687T3
ES2038687T3 ES198787402708T ES87402708T ES2038687T3 ES 2038687 T3 ES2038687 T3 ES 2038687T3 ES 198787402708 T ES198787402708 T ES 198787402708T ES 87402708 T ES87402708 T ES 87402708T ES 2038687 T3 ES2038687 T3 ES 2038687T3
Authority
ES
Spain
Prior art keywords
pirrol
preparation
new derivatives
procedure
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787402708T
Other languages
English (en)
Inventor
Jean-Dominique Bourzat
Marc Capet
Claude Cotrel
Richard Labaudiniere
Philippe Pitchen
Gerard Roussel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Application granted granted Critical
Publication of ES2038687T3 publication Critical patent/ES2038687T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Rolls And Other Rotary Bodies (AREA)
  • Indole Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

NUEVOS DERIVADOS DE FORMULA (I) EN LA QUE A FORMA CON EL CICLO PIRROL UN NUCLEO DE ISOINDOLINA CON SUSTITUYENTES QUE SE DETALLAN EN LA INVENCION. PREPARACION DE SUS SALES FARMACEUTICAMENTE ACEPTABLES Y LOS ISOMEROS OPTICOS DE LOS PRODUCTOS DE FORMULA (I). ESTOS COMPUESTOS SON UTILES COMO ANSIOLITICOS.
ES198787402708T 1986-12-02 1987-12-01 Procedimiento para la preparacion de nuevos derivados del pirrol. Expired - Lifetime ES2038687T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8616796A FR2607504B1 (fr) 1986-12-02 1986-12-02 Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2038687T3 true ES2038687T3 (es) 1993-08-01

Family

ID=9341443

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787402708T Expired - Lifetime ES2038687T3 (es) 1986-12-02 1987-12-01 Procedimiento para la preparacion de nuevos derivados del pirrol.

Country Status (23)

Country Link
EP (1) EP0271404B1 (es)
JP (1) JPS63154682A (es)
KR (1) KR880007517A (es)
AT (1) ATE66219T1 (es)
AU (1) AU594215B2 (es)
CA (1) CA1298295C (es)
DE (1) DE3772172D1 (es)
DK (1) DK169969B1 (es)
ES (1) ES2038687T3 (es)
FI (1) FI84723C (es)
FR (1) FR2607504B1 (es)
GR (1) GR3002490T3 (es)
HU (1) HU197573B (es)
IE (1) IE61089B1 (es)
IL (1) IL84658A (es)
MA (1) MA21118A1 (es)
MX (1) MX9558A (es)
NO (1) NO166037C (es)
NZ (1) NZ222752A (es)
OA (1) OA08696A (es)
PT (1) PT86261B (es)
SU (3) SU1616515A3 (es)
ZA (1) ZA879001B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607506B1 (fr) * 1986-12-02 1989-01-06 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
CZ309617B6 (cs) * 2019-04-05 2023-05-24 Ústav organické chemie a biochemie AV ČR, v. v. i 3α5ß-Neuroaktivní steroidy pro léčbu epilepsie a záchvatových onemocnění

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2101081B1 (es) * 1970-08-19 1974-01-11 Rhone Poulenc Sa
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
AR207555A1 (es) * 1972-12-04 1976-10-15 Procedimiento para preparar aril-6-piperazinocarboniloxi-5 oxo-7 tetrahidro-2,3,6,7 ditiino(1,4)(2,3-c)pirroles
ZA756953B (en) * 1974-11-07 1976-10-27 Rhone Poulenc Ind 1,4-oxathiino(2,3-c)pyrrole derivatives
AR208414A1 (es) * 1974-11-07 1976-12-27 Rhone Poulenc Ind Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
ATE39483T1 (de) * 1982-04-02 1989-01-15 Takeda Chemical Industries Ltd Kondensierte pyrrolinon-derivate, und ihre herstellung.
FR2559484B2 (fr) * 1983-07-06 1986-09-26 Provesan Sa Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS6169773A (ja) * 1984-09-14 1986-04-10 Takeda Chem Ind Ltd イソインドリノン誘導体
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
FR2607506B1 (fr) * 1986-12-02 1989-01-06 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO875012D0 (no) 1987-12-01
EP0271404A2 (fr) 1988-06-15
DE3772172D1 (de) 1991-09-19
FI84723C (fi) 1992-01-10
ATE66219T1 (de) 1991-08-15
MX9558A (es) 1993-11-01
MA21118A1 (fr) 1988-07-01
GR3002490T3 (en) 1992-12-30
HUT46007A (en) 1988-09-28
CA1298295C (fr) 1992-03-31
SU1685264A3 (ru) 1991-10-15
DK169969B1 (da) 1995-04-18
PT86261B (pt) 1990-11-07
NO875012L (no) 1988-06-03
AU594215B2 (en) 1990-03-01
NO166037B (no) 1991-02-11
DK630487D0 (da) 1987-12-01
FI875299A7 (fi) 1988-06-03
IL84658A0 (en) 1988-04-29
OA08696A (fr) 1989-03-31
KR880007517A (ko) 1988-08-27
SU1657056A3 (ru) 1991-06-15
SU1616515A3 (ru) 1990-12-23
IL84658A (en) 1992-01-15
AU8193687A (en) 1988-06-02
ZA879001B (en) 1988-06-01
IE873252L (en) 1988-06-02
FR2607504A1 (fr) 1988-06-03
EP0271404B1 (fr) 1991-08-14
FI875299A0 (fi) 1987-12-01
NO166037C (no) 1991-05-22
FR2607504B1 (fr) 1989-01-27
FI84723B (fi) 1991-09-30
IE61089B1 (en) 1994-09-21
HU197573B (en) 1989-04-28
DK630487A (da) 1988-06-03
EP0271404A3 (en) 1989-04-05
JPS63154682A (ja) 1988-06-27
PT86261A (fr) 1988-01-01
NZ222752A (en) 1989-10-27

Similar Documents

Publication Publication Date Title
ES2082481T3 (es) Procedimiento para la preparacion de intermedios de la sertralina.
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES2059491T3 (es) Derivados de indol con anillos condensados.
ES2037013T3 (es) Procedimiento para preparar tieno-1,4-diazepinas.
ES2101063T3 (es) Derivados monofluorados de n-propargil-1-amino-indano y su utilizacion como inhibidores de la monoamin-oxidasa.
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
ES2113867T3 (es) Imino-derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
MX9605613A (es) Procedimiento para preparar formas anhidras e hidratadas de derivados de piperidina antihistaminica, polimorfos y pseudomorfos de los mismos.
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ES8505681A1 (es) Procedimiento para preparar n2-acil-9-(1, 3-dihidroxi-2-propoximetil)-guaninas y sus sales farmaceuticamente aceptables
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
ES2076147T3 (es) Nuevos derivados de amina ciclicos, medicamento que contiene estos compuestos y procedimiento para su preparacion.
ES2072263T3 (es) Derivados de 4-aminopiridina.
ES2142030T3 (es) Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR209755A1 (es) Nuevos compuestos derivados de la 2-hidroxi-c1-4-alquil sustituido benzofenoxima,utiles como productos intermediarios,que son terapeuticamente inactivos y particularmente apropiados para la preparacion de los correspondientes derivados benzisoxozolicos biologicamente activos
ES8900048A1 (es) Procedimiento para la obtencion de quinoloncarboxilatos
ES477520A1 (es) Procedimiento para la preparacion de nuevas penicilinas.
ES452200A1 (es) Un procedimiento para la preparacion de nuevos derivados de pipendina.
ES2078749T3 (es) Procedimiento para preparar sertralina.
ES484327A1 (es) Procedimiento para la obtencion de 2-imino-1,3-tiaza-ciclo- alcanos
MX9305093A (es) Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
ES480565A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,2 y 1,3 (di-0-n-alquil)glicerilo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 271404

Country of ref document: ES